U S PHYSICAL THERAPY INC /NV: stockholders equity
Stockholders equity for U S PHYSICAL THERAPY INC /NV. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All U S PHYSICAL THERAPY INC /NV financial histories
What this measure means
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
Exact concept: us-gaap:StockholdersEquity. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2010-12-31 to 2025-12-31. The SEC response was captured on 2026-09-19.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 476,432,000 | USD | 2026-02-27 | 10-K · 0001140361-26-007170 |
| At date | 2024-12-31 | 488,929,000 | USD | 2026-02-27 | 10-K · 0001140361-26-007170 |
| At date | 2023-12-31 | 476,194,000 | USD | 2025-03-03 | 10-K · 0001140361-25-006750 |
| At date | 2022-12-31 | 315,793,000 | USD | 2024-02-29 | 10-K · 0001140361-24-010454 |
| At date | 2021-12-31 | 295,606,000 | USD | 2023-02-28 | 10-K · 0001140361-23-009198 |
| At date | 2020-12-31 | 276,160,000 | USD | 2022-03-01 | 10-K · 0001140361-22-007247 |
| At date | 2019-12-31 | 240,257,000 | USD | 2021-03-01 | 10-K · 0001140361-21-006642 |
| At date | 2018-12-31 | 215,945,000 | USD | 2020-02-28 | 10-K · 0001140361-20-004374 |
| At date | 2017-12-31 | 204,866,000 | USD | 2019-03-18 | 10-K · 0001140361-19-005059 |
| At date | 2016-12-31 | 187,548,000 | USD | 2018-03-14 | 10-K · 0001140361-18-013378 |
| At date | 2016-09-30 | 184,235,000 | USD | 2017-06-07 | 10-K · 0001140361-17-024382 |
| At date | 2016-06-30 | 180,289,000 | USD | 2017-06-07 | 10-K · 0001140361-17-024382 |
| At date | 2016-03-31 | 174,733,000 | USD | 2017-06-07 | 10-K · 0001140361-17-024382 |
| At date | 2015-12-31 | 171,057,000 | USD | 2017-06-07 | 10-K · 0001140361-17-024382 |
| At date | 2015-09-30 | 166,839,000 | USD | 2017-06-07 | 10-K · 0001140361-17-024382 |
| At date | 2015-06-30 | 161,329,000 | USD | 2017-06-07 | 10-K · 0001140361-17-024382 |
| At date | 2015-03-31 | 156,107,000 | USD | 2017-06-07 | 10-K · 0001140361-17-024382 |
| At date | 2014-12-31 | 146,280,000 | USD | 2016-03-04 | 10-K · 0001567619-16-001931 |
| At date | 2013-12-31 | 128,290,000 | USD | 2015-03-12 | 10-K · 0001140361-15-011450 |
| At date | 2012-12-31 | 117,323,000 | USD | 2014-03-11 | 10-K · 0001193125-14-093159 |
| At date | 2011-12-31 | 107,049,000 | USD | 2013-03-12 | 10-K · 0001193125-13-102877 |
| At date | 2010-12-31 | 103,957,000 | USD | 2012-03-09 | 10-K · 0001193125-12-106052 |
Related financial histories
- U S PHYSICAL THERAPY INC /NV: total assets
- U S PHYSICAL THERAPY INC /NV: total liabilities
- U S PHYSICAL THERAPY INC /NV: cash and cash equivalents
- U S PHYSICAL THERAPY INC /NV: net income or loss
- U S PHYSICAL THERAPY INC /NV: operating cash flow
- U S PHYSICAL THERAPY INC /NV: revenue
- U S PHYSICAL THERAPY INC /NV: contract revenue excluding tax
- U S PHYSICAL THERAPY INC /NV: financing cash flow
- U S PHYSICAL THERAPY INC /NV: investing cash flow
- U S PHYSICAL THERAPY INC /NV: retained earnings or deficit
- U S PHYSICAL THERAPY INC /NV: basic weighted-average shares
- U S PHYSICAL THERAPY INC /NV: diluted weighted-average shares
- U S PHYSICAL THERAPY INC /NV: basic earnings per share
- U S PHYSICAL THERAPY INC /NV: diluted earnings per share
- U S PHYSICAL THERAPY INC /NV: income tax expense or benefit
- U S PHYSICAL THERAPY INC /NV: net property, plant and equipment
- U S PHYSICAL THERAPY INC /NV: share-based compensation expense
- U S PHYSICAL THERAPY INC /NV: operating income or loss
- U S PHYSICAL THERAPY INC /NV: current assets
- U S PHYSICAL THERAPY INC /NV: interest expense
- U S PHYSICAL THERAPY INC /NV: current liabilities
- U S PHYSICAL THERAPY INC /NV: goodwill carrying amount
- U S PHYSICAL THERAPY INC /NV: net finite-lived intangible assets
- U S PHYSICAL THERAPY INC /NV: net current accounts receivable
- U S PHYSICAL THERAPY INC /NV: common-stock repurchase payments
- U S PHYSICAL THERAPY INC /NV: gross profit
- U S PHYSICAL THERAPY INC /NV: selling, general and administrative expense
Inspect the source
- Entity
- U S PHYSICAL THERAPY INC /NV / CIK 0000885978
- Captured
- 2026-09-19T11:15:04.433Z
- SEC response SHA-256
b015152c5ccce31d39dc5f188bff4fcaf60e16d4b7fb4e3a1b945f4225cf3156
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000885978.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))